CyberKnife SBRT

Despite its name, CyberKnife involves no cutting and offers a non-invasive alternative to surgery for many patients. Stereotactic body radiation therapy (SBRT) involves high doses of radiation delivered in a small number of treatment sessions. This is what you can expect:

• Before treatment, small metallic markers are placed in the prostate or kidney (depending on the cancer type) so the CyberKnife robot can accurately monitor the cancer’s location at all times. For prostate cancer, the markers are inserted during a procedure similar to a prostate biopsy, through the rectum. For renal cancer, the markers are placed through the upper abdomen in a procedure called interventional radiology.
• About a week after the marker placement, both a CT scan and an MRI are taken. The images are merged using specialized software to provide a clear picture of the cancerous region, including healthy surrounding tissue, from which the physicians create a treatment plan.
• A robotic arm delivers pencil-thin beams of radiation that can be directed from potentially thousands of angles, allowing a high dose to bombard cancerous cells with great accuracy and minimizing exposure to healthy neighboring tissues. Because the technology can detect motion during treatment, the CyberKnife robot continuously corrects the aim of the radiation beam, further ensuring accuracy.
• Each session will last less than one hour and is painless. No urinary catheter is necessary. On treatment days, patients are typically asked to perform an enema prior to the session.

Selecting a treatment for your cancer is a personal decision. When making that decision, it is important to understand:

• The nature of your diagnosis.
• Available treatment options.
• Benefits, risks, and side effects of each treatment option.

You may want to discuss your diagnosis and treatment plan with family and friends, and read the stories of other patients (see link above) who had the same diagnosis.

Schedule a Consult

Talking with a physician is the best way to determine if CyberKnife is right for you. Click above to schedule a consult or Call (513) 841-7690. 

If you have prostate or renal cancer and radiation treatment is recommended, CyberKnife may be an ideal option.

Key benefits include:

• Despite its name, CyberKnife requires no cutting.
• Fewer treatments – typically five sessions compared with 40 or more for traditional radiation.
• It can be completed in one week, not months.
• It delivers high doses of radiation with pinpoint accuracy, meaning minimum effect to the rest of the body.
• It enables a shorter recovery time.

The Urology Group offers one of the most advanced independent centers of excellence for urologic care in the country. This singular focus means our team of physicians and staff is specialized to deliver the best possible treatment for prostate and renal cancer patients.

Steve’s Story

It was 2013 when The Urology Group introduced the CyberKnife to Cincinnati. Eleven years later, in July 2024, Steve Rouff became the 4,000th patient to choose this non-invasive radiation treatment option to eradicate his prostate cancer.
Read More

Carlos’s Story

Although Carlos is nearing 70, he is as active as someone decades younger. And he’s happy to report he does not have prostate cancer. But that wasn’t always the case.
Read More

Charles’s Story

It was Charles’ wife who insisted he go to the urologist. “I had blood in my urine. Turns out it was prostate cancer. I was stunned.” Today, almost 10 years later, Charles is stunned at how good he feels.
Read More

Jon’s Story

As an attorney with a solo practice, Jon didn’t want to let his clients down by missing a lot of time during his prostate cancer treatment. With CyberKnife completing treatments in just five session, plus minimal side effects, it was the right option for Jon.
Read More

Tom’s Story

The combination of CyberKnife’s advanced technology and top quality patient care made Tom’s experience with prostate cancer relatively pain-free.
Read More

Scott’s Story

What he thought was an ordinary drive home from a baseball game turned out to be a defining moment in Scott’s life. He got the call: at age 61 he was diagnosed with prostate cancer.

Scott, a retired orthopedic surgeon, began extensive research on prostate cancer and the various treatments. He spoke with a number of prostate cancer patients about their treatments and the problems they encountered. Around the same time, one of Scott’s friends attended a prostate cancer seminar and brought him back information about the CyberKnife® Robotic Radiosurgery System.
Read More